Cargando…

Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment

BACKGROUND: Obtaining insight into patients’ preferences is important to optimize cancer care. We investigated patients’ preferences for surgical management of esophageal cancer. METHODS: We conducted a discrete choice experiment among adult patients who had undergone esophagectomy for adenocarcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bekker-Grob, Esther W., Niers, Eva J., van Lanschot, J. Jan B., Steyerberg, Ewout W., Wijnhoven, Bas P. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554743/
https://www.ncbi.nlm.nih.gov/pubmed/26170156
http://dx.doi.org/10.1007/s00268-015-3148-8
_version_ 1782388083590692864
author de Bekker-Grob, Esther W.
Niers, Eva J.
van Lanschot, J. Jan B.
Steyerberg, Ewout W.
Wijnhoven, Bas P. L.
author_facet de Bekker-Grob, Esther W.
Niers, Eva J.
van Lanschot, J. Jan B.
Steyerberg, Ewout W.
Wijnhoven, Bas P. L.
author_sort de Bekker-Grob, Esther W.
collection PubMed
description BACKGROUND: Obtaining insight into patients’ preferences is important to optimize cancer care. We investigated patients’ preferences for surgical management of esophageal cancer. METHODS: We conducted a discrete choice experiment among adult patients who had undergone esophagectomy for adenocarcinoma or squamous cell cancer of the esophagus. Patients’ preferences were quantified with regression analysis using scenarios based on five aspects: risk of in-hospital mortality, risk of persistent symptoms, chance of 5-year survival, risk of surgical and non-surgical complications, and hospital volume of esophageal cancer surgery. RESULTS: The response rate was 68 % (104/142). All aspects proved to influence patients’ preferences (p < 0.05). Persisting gastrointestinal symptoms and 5-year survival were the most important attributes, but preferences varied between patients. On average, patients were willing to trade-off 9.5 % (CI 2.4–16.6 %) 5-year survival chance to obtain a surgical treatment with 30 % lower risk of gastrointestinal symptoms, or 8.1 % (CI 4.0–12.2 %) 5-year survival chance for being treated in a high instead of a low-volume hospital. CONCLUSIONS: Patients are willing to trade-off some 5-year survival chance to achieve an improvement in early outcomes. Given the preference heterogeneity among participants, the present study underlines the importance of a patient-tailored approach when discussing prognosis and treatment.
format Online
Article
Text
id pubmed-4554743
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-45547432015-09-04 Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment de Bekker-Grob, Esther W. Niers, Eva J. van Lanschot, J. Jan B. Steyerberg, Ewout W. Wijnhoven, Bas P. L. World J Surg Original Scientific Report BACKGROUND: Obtaining insight into patients’ preferences is important to optimize cancer care. We investigated patients’ preferences for surgical management of esophageal cancer. METHODS: We conducted a discrete choice experiment among adult patients who had undergone esophagectomy for adenocarcinoma or squamous cell cancer of the esophagus. Patients’ preferences were quantified with regression analysis using scenarios based on five aspects: risk of in-hospital mortality, risk of persistent symptoms, chance of 5-year survival, risk of surgical and non-surgical complications, and hospital volume of esophageal cancer surgery. RESULTS: The response rate was 68 % (104/142). All aspects proved to influence patients’ preferences (p < 0.05). Persisting gastrointestinal symptoms and 5-year survival were the most important attributes, but preferences varied between patients. On average, patients were willing to trade-off 9.5 % (CI 2.4–16.6 %) 5-year survival chance to obtain a surgical treatment with 30 % lower risk of gastrointestinal symptoms, or 8.1 % (CI 4.0–12.2 %) 5-year survival chance for being treated in a high instead of a low-volume hospital. CONCLUSIONS: Patients are willing to trade-off some 5-year survival chance to achieve an improvement in early outcomes. Given the preference heterogeneity among participants, the present study underlines the importance of a patient-tailored approach when discussing prognosis and treatment. Springer International Publishing 2015-07-14 2015 /pmc/articles/PMC4554743/ /pubmed/26170156 http://dx.doi.org/10.1007/s00268-015-3148-8 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Scientific Report
de Bekker-Grob, Esther W.
Niers, Eva J.
van Lanschot, J. Jan B.
Steyerberg, Ewout W.
Wijnhoven, Bas P. L.
Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
title Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
title_full Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
title_fullStr Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
title_full_unstemmed Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
title_short Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment
title_sort patients’ preferences for surgical management of esophageal cancer: a discrete choice experiment
topic Original Scientific Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554743/
https://www.ncbi.nlm.nih.gov/pubmed/26170156
http://dx.doi.org/10.1007/s00268-015-3148-8
work_keys_str_mv AT debekkergrobestherw patientspreferencesforsurgicalmanagementofesophagealcanceradiscretechoiceexperiment
AT niersevaj patientspreferencesforsurgicalmanagementofesophagealcanceradiscretechoiceexperiment
AT vanlanschotjjanb patientspreferencesforsurgicalmanagementofesophagealcanceradiscretechoiceexperiment
AT steyerbergewoutw patientspreferencesforsurgicalmanagementofesophagealcanceradiscretechoiceexperiment
AT wijnhovenbaspl patientspreferencesforsurgicalmanagementofesophagealcanceradiscretechoiceexperiment